Brief: Evolus Q2 Net Income USD -18.14 Million
02/08/2023 21:05
Aug 02 (Reuters) - Evolus Q2 adjusted gross margin 70.2%. * Q2 gross margin 68.7% * Q2 gross profit USD 33.895 million * Outlook FY Sales USD 185-195 Million * Outlook FY Sales Growth 30%
Recent news on Evolus
See all newsEvolus Inc reports results for the quarter ended June 30 - Earnings Summary
Evolus Q2 revenue rises 21%, lifts 2026 outlook
Brief: Evolus Q2 Product Revenue USD 83.35 Million
Evolus Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Evolus Announces Commercial Launch Of Estyme® Injectable Hyaluronic Acid Gels In Europe